RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 88 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,692,177 | -12.2% | 221,201 | -14.3% | 0.00% | 0.0% |
| Q2 2023 | $1,927,073 | +137548.1% | 257,975 | +22.9% | 0.00% | 0.0% |
| Q1 2023 | $1,400 | -11.7% | 209,878 | +2.1% | 0.00% | 0.0% |
| Q4 2022 | $1,585 | -99.9% | 205,587 | +0.4% | 0.00% | -33.3% |
| Q3 2022 | $2,178,000 | +41.8% | 204,724 | +8.5% | 0.00% | +50.0% |
| Q2 2022 | $1,536,000 | +73.2% | 188,666 | +52.3% | 0.00% | +100.0% |
| Q1 2022 | $887,000 | -56.5% | 123,892 | +4.0% | 0.00% | -66.7% |
| Q4 2021 | $2,040,000 | +250.5% | 119,074 | +370.9% | 0.00% | +200.0% |
| Q3 2021 | $582,000 | -23.4% | 25,284 | +21.5% | 0.00% | 0.0% |
| Q2 2021 | $760,000 | – | 20,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $77,730,340 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $44,380,166 | 32.86% |
| MV Management XI, L.L.C. | 1,971,908 | $14,730,153 | 25.77% |
| MIC Capital Management UK LLP | 8,451,758 | $63,134,635 | 12.84% |
| Yong Rong (HK) Asset Management Ltd | 1,174,200 | $8,772 | 3.85% |
| ArchPoint Investors | 1,114,626 | $8,326,256 | 3.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,711,148 | $20,252,276 | 0.70% |
| HARVARD MANAGEMENT CO INC | 882,129 | $6,590 | 0.65% |
| Diametric Capital, LP | 119,906 | $895,698 | 0.40% |
| Lingotto Investment Management LLP | 775,077 | $5,789,825 | 0.37% |